Katzka, D. A. (2024). Much ado about EoE. Gut, gutjnl-2024-334394. https://doi.org/10.1136/gutjnl-2024-334394

Lian, G., Malagola, E., Wei, C., Shi, Q., Zhao, J., Hata, M., Kobayashi, H., Ochiai, Y., Zheng, B., Zhi, X., Wu, F., Tu, R., Nápoles, O. C., Su, W., Li, L., Jing, C., Chen, M., Zamechek, L., Friedman, R., … Wang, T. C. (2024). p53 mutation biases squamocolumnar junction progenitor cells towards dysplasia rather than metaplasia in Barrett’s oesophagus. Gut, gutjnl-2024-332095. https://doi.org/10.1136/gutjnl-2024-332095

Huang, X.-B., Huang, Q., Jiang, M.-C., Zhong, Q., Zheng, H.-L., Wang, J.-B., Huang, Z.-N., Wang, H.-G., Liu, Z.-Y., Li, Y.-F., Xu, K.-X., Lin, M., Li, P., Huang, Z.-H., Xie, J.-W., Lin, J.-X., Lu, J., Que, J.-W., Zheng, C.-H., … Huang, C.-M. (2024). KLHL21 suppresses gastric tumourigenesis via maintaining STAT3 signalling equilibrium in stomach homoeostasis. Gut, gutjnl-2023-331111. https://doi.org/10.1136/gutjnl-2023-331111

Kreimeyer, H., Gonzalez, C. G., Fondevila, M. F., Hsu, C. L., Hartmann, P., Zhang, X., Stärkel, P., Bosques-Padilla, F., Verna, E. C., Abraldes, J. G., Brown, R. S., Vargas, V., Altamirano, J., Caballería, J., Shawcross, D. L., Louvet, A., Lucey, M. R., Mathurin, P., Garcia-Tsao, G., … Schnabl, B. (2024). Faecal proteomics links neutrophil degranulation with mortality in patients with alcohol-associated hepatitis. Gut, gutjnl-2024-332730. https://doi.org/10.1136/gutjnl-2024-332730

Raju, S. A., Greenaway, E. A., Schiepatti, A., Arpa, G., Vecchione, N., Jian, C. L., Grobler, C., Maregatti, M., Green, O., Bowker-Howell, F. J., Shiha, M. G., Penny, H. A., Cross, S. S., Ciacci, C., Rostami, K., Ahmadipour, S., Moradi, A., Rostami-Nejad, M., Biagi, F., … Sanders, D. S. (2024). New entity of adult ultra-short coeliac disease: the first international cohort and case–control study. Gut, 73(7), 1124–1130. https://doi.org/10.1136/gutjnl-2023-330913

Elkin, E. B., & Hur, C. (2023). Antiobesity interventions: options, evidence and value. Gut, 73(6), 886–887. https://doi.org/10.1136/gutjnl-2023-330768

Zhang, F., Sahu, V., Peng, K., Wang, Y., Li, T., Bala, P., Aitymbayev, D., Sahgal, P., Schaefer, A., Der, C. J., Ryeom, S., Yoon, S., Sethi, N., Bass, A. J., & Zhang, H. (2024). Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut, 73(8), 1280–1291. https://doi.org/10.1136/gutjnl-2023-329686

Ben-Ami, R., Wang, Q.-L., Zhang, J., Supplee, J. G., Fahrmann, J. F., Lehmann-Werman, R., Brais, L. K., Nowak, J., Yuan, C., Loftus, M., Babic, A., Irajizad, E., Davidi, T., Zick, A., Hubert, A., Neiman, D., Piyanzin, S., Gal-Rosenberg, O., Horn, A., … Wolpin, B. M. (2023). Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Gut, gutjnl-2023-331074. https://doi.org/10.1136/gutjnl-2023-331074

Lu, H., Cao, L. L., Ballout, F., Belkhiri, A., Peng, D., Chen, L., Chen, Z., Soutto, M., Wang, T. C., Que, J., Giordano, S., Washington, M. K., Chen, S., McDonald, O. G., Zaika, A., & El-Rifai, W. (2023). Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma. Gut, 73(1), 47–62. https://doi.org/10.1136/gutjnl-2023-329455

Hirano, I., & Katzka, D. (2023). Comparing the relative efficacy of therapeutics for eosinophilic oesophagitis: is counting eosinophils the right target? Gut, 72(11), 2007–2008. https://doi.org/10.1136/gutjnl-2023-330705

Quante, M., Wang, T. C., & Bass, A. J. (2022). Adenocarcinoma of the oesophagus: is it gastric cancer? Gut, 72(6), 1027–1029. https://doi.org/10.1136/gutjnl-2022-327096

Martin-Serrano, M. A., Kepecs, B., Torres-Martin, M., Bramel, E. R., Haber, P. K., Merritt, E., Rialdi, A., Param, N. J., Maeda, M., Lindblad, K. E., Carter, J. K., Barcena-Varela, M., Mazzaferro, V., Schwartz, M., Affo, S., Schwabe, R. F., Villanueva, A., Guccione, E., Friedman, S. L., … Sia, D. (2022). Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications. Gut, 72(4), 736–748. https://doi.org/10.1136/gutjnl-2021-326514

Hsu, N.-Y., Nayar, S., Gettler, K., Talware, S., Giri, M., Alter, I., Argmann, C., Sabic, K., Thin, T. H., Ko, H.-B. M., Werner, R., Tastad, C., Stappenbeck, T., Azabdaftari, A., Uhlig, H. H., Chuang, L.-S., & Cho, J. H. (2022). NOX1 is essential for TNFα-induced intestinal epithelial ROS secretion and inhibits M cell signatures. Gut, 72(4), 654–662. https://doi.org/10.1136/gutjnl-2021-326305

Chen, L., Lu, H., Peng, D., Cao, L. L., Ballout, F., Srirmajayam, K., Chen, Z., Bhat, A., Wang, T. C., Capobianco, A., Que, J., McDonald, O. G., Zaika, A., Zhang, S., & El-Rifai, W. (2022). Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma. Gut, 72(3), 421–432. https://doi.org/10.1136/gutjnl-2022-327076

Schiepatti, A., Sanders, D. S., Baiardi, P., Caio, G., Ciacci, C., Kaukinen, K., Lebwohl, B., Leffler, D., Malamut, G., Murray, J. A., Rostami, K., Rubio-Tapia, A., Volta, U., & Biagi, F. (2022). Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus. Gut, 71(11), 2218–2225. https://doi.org/10.1136/gutjnl-2021-326645

Forbes, N., Elmunzer, B. J., Keswani, R. N., Hilsden, R. J., Hall, M., Anderson, J. T., Arvanitakis, M., Chen, Y.-I., Duloy, A., Elta, G. H., Maranki, J. L., Mergener, K., Petersen, B. T., Sethi, A., Siersema, P. D., Smith, Z. L., Telford, J. J., Tse, F., Cotton, P. B., & Wani, S. (2022). Consensus-based development of a causal attribution system for post-ERCP adverse events. Gut, 71(10), 1963–1966. https://doi.org/10.1136/gutjnl-2022-328059

Ventura-Cots, M., Argemi, J., Jones, P. D., Lackner, C., El Hag, M., Abraldes, J. G., Alvarado, E., Clemente, A., Ravi, S., Alves, A., Alboraie, M., Altamirano, J., Barace, S., Bosques, F., Brown, R., Caballeria, J., Cabezas, J., Carvalhana, S., Cortez-Pinto, H., … Bataller, R. (2022). Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. Gut, 71(9), 1856–1866. https://doi.org/10.1136/gutjnl-2021-324295

Simon, T. G., Roelstraete, B., Hagström, H., Sundström, J., & Ludvigsson, J. F. (2021). Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut, 71(9), 1867–1875. https://doi.org/10.1136/gutjnl-2021-325724

Bergman, D., King, J., Lebwohl, B., Clements, M. S., Roelstraete, B., Kaplan, G. G., Green, P. H., Murray, J. A., & Ludvigsson, J. F. (2021). Two waves of coeliac disease incidence in Sweden: a nationwide population-based cohort study from 1990 to 2015. Gut, 71(6), 1088–1094. https://doi.org/10.1136/gutjnl-2021-324209

Zhou, J., Wu, Z., Zhang, Z., Goss, L., McFarland, J., Nagaraja, A., Xie, Y., Gu, S., Peng, K., Zeng, Y., Zhang, X., Long, H., Nakagawa, H., Rustgi, A., Diehl, J. A., Meyerson, M., Wong, K.-K., & Bass, A. (2021). Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma. Gut, 71(4), 665–675. https://doi.org/10.1136/gutjnl-2020-323276

Olazagoitia-Garmendia, A., Zhang, L., Mera, P., Godbout, J. K., Sebastian-DelaCruz, M., Garcia-Santisteban, I., Mendoza, L. M., Huerta, A., Irastorza, I., Bhagat, G., Green, P. H., Herrero, L., Serra, D., Rodriguez, J. A., Verdu, E. F., He, C., Bilbao, J. R., & Castellanos-Rubio, A. (2021). Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells. Gut, 71(1), 68–76. https://doi.org/10.1136/gutjnl-2020-322566